$BBWI

Bath & Body Works (BBWI) reported Q2 revenue of $1.51B, down 2.3% YoY, beating estimates by 1.2%. EPS beat but missed guidance. Stock up 14.9%. Ulta (ULTA) reported $3.04B revenue, up 8.9% YoY, beating estimates. Stock up 11.6%. Sally Beauty (SBH) reported flat revenue, in line with estimates. Stock up 10.6%. Warby Parker (WRBY) reported $235.5M revenue, up 9.8% YoY, missing estimates by 1%. Stock down 12.7%.

Bath & Body Works is expanding its partnership with Ulta Beauty for the holidays, introducing exclusive products like the discontinued Pink Suede fragrance. This move is part of a strategy to reach customers beyond its own stores, as the company faces a 5.4% decline in in-store sales. Deloitte expects holiday spending to rise 4% to $1,654 per household.

Bath & Body Works reports a 5.4% decline in U.S. and Canadian store sales in Q2 2026, despite a 5% increase in mall visits. The company plans to shift 75% of stores outside malls, citing better performance in off-mall locations. Direct sales grew by 3%, while international sales increased by 24.9%. The retailer aims to improve store navigation and expand distribution through Amazon and Ulta Beauty.

Bath & Body Works plans to open seven new UK stores by year-end, expanding its presence to 21 locations. The company views the UK as a key market, despite cautious consumer spending. According to the British Retail Consortium, retail sales growth remained weak in September, but health and beauty saw strong sales.

Wells Fargo analyst Ike Boruchow maintained a Buy rating on Bath & Body Works (BBWI) with a $24.00 price target. On Holding AG (ONON) received a Buy rating from Citi's Paul Lejuez and a $38.00 target from Berenberg Bank. BBWI closed at $16.45, ONON at $29.96. Analyst consensus: BBWI Hold ($22.20 target), ONON Strong Buy ($42.57 target).

Bath & Body Works (BBWI) introduced a new hypoallergenic product line, Essentials, targeting the $100B sensitive skin market. The line includes body washes and lotions, launched on September 28.

Bath & Body Works (BBWI) granted CEO Daniel Heaf a performance stock unit award worth $10 million, or 591,366 shares, tied to stock price targets and relative performance over four years. The award vests based on share prices between $40 and $100 and total shareholder return compared to the S&P 1500 Consumer Discretionary Distribution & Retail Index.

Bath & Body Works, Inc. (BBWI) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On September 21, 2026, the Human Capital and Compensation Committee of the Board of Directors of Bath & Body Works, Inc. (

Barington Capital Group has taken an activist stake in Bath & Body Works (BBWI), pushing for a potential sale, share repurchases, and board seats, citing undervaluation. Shares closed at $17.19, down 31.78% over a year. Analysts and models suggest fair value estimates between $24.06 and $39.78, indicating a significant discount. The company faces risks like mall exposure and shifting consumer tastes.

Barington Capital Group disclosed a stake in Bath & Body Works, urging a sale, share repurchases, and board changes. The activist's push challenges the company's capital allocation strategy, focusing on digital upgrades and expansion. Analysts project 2029 revenue of $7.6B and earnings of $708.4M, with a 53% potential upside. Risks include digital underperformance and margin pressures.